Harnessing the Power of Antibodies, Peptides, & Small Molecules to Optimize RLT Performance

• Comparing antibodies, antibody fragments, peptides, and small molecules for different RLT applications
• Evaluating how moiety choice influences tumor uptake, internalization, and off-target exposure
• Applying practical lessons to match targeting format with clinical objectives and therapeutic strategy

Speakers:

Kirstin Zettlitz

Target Biology Lead

Stealth Radiopharma